ACLY and autoimmune polyendocrinopathy: Among aPL tests, LA has been shown to be the strongest risk factor for thrombotic events (15) and LA testing should always be performed in parallel with aCL and aβ2GPI (3, 16–18) when a patients is investigated for APS.